Korea Otsuka Pharmaceutical Co., Ltd.

Pharma

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Activity

Key Events

Nov 30, 2024TrialRegistry on the Effectiveness and Safety of the 9-month MDR-END Treatment Regimen in Korean Patients with FQ-sensitive MDR-TB (MDR-END Registry)

Oct 7, 2021TrialPost-Marketing Surveillance of Safety and Effectiveness of Mucosta®SR Tab.

Dec 30, 2019TrialA Study to Evaluate the Efficacy and Safety of MCT-SR in Patients With Gastritis

Jul 5, 2019TrialTo Evaluate Food Effect on the Pharmacokinetics of Rebamipide in Healthy Volunteers

Jul 1, 2019TrialEvaluating the Safety and effectivenesS in Adult KorEaN Patients Treated With Tolvaptan for Management of Autosomal domInAnt poLycystic Kidney Disease

Apr 22, 2019TrialTo Evaluate Pharmacokinetics and Safety of Two Different Formulation of Rebamipide in Healthy Volunteers

Aug 7, 2018TrialIclusig PMS in CML or Ph+ALL Patients

Feb 22, 2018TrialA Study of Abilify® Tablet(Aripiprazole) as an Adjunctive Treatment in the Bipolar Depression

1 more events

Nov 21, 2017TrialMAintain the Efficacy and Safety in Treatment of Schizophrenia After Switching to Long-acTing Injectable aRipiprazole From Oral Atypical Antipsychotics

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Regulatory

Regulatory Timeline

19854 events

FDASep 17

Dextrose 10% In Plastic Container — DEXTROSE 5% IN PLASTIC CONTAINER

Application NDA019479 (NDA)

FDASep 17

Dextrose 10% In Plastic Container — DEXTROSE 5% IN PLASTIC CONTAINER

Application NDA019479 (NDA)

FDAJul 15

Dextrose 10% In Plastic Container — DEXTROSE 5% IN PLASTIC CONTAINER

Application NDA019466 (NDA)

FDAJul 15

Dextrose 10% In Plastic Container — DEXTROSE 5% IN PLASTIC CONTAINER

Application NDA019466 (NDA)

19883 events

FDAFeb 29

Bacteriostatic Water For Injection In Plastic Container — STERILE WATER FOR INJECTION IN PLASTIC CONTAINER

Application NDA019633 (NDA)

FDAFeb 2

Dextrose 10% In Plastic Container — DEXTROSE 10% IN PLASTIC CONTAINER

Application NDA019626 (NDA)

FDAFeb 2

Dextrose 10% In Plastic Container — DEXTROSE 10% IN PLASTIC CONTAINER

Application NDA019626 (NDA)

19895 events

FDADec 26

Bacteriostatic Water For Injection In Plastic Container — STERILE WATER FOR INJECTION IN PLASTIC CONTAINER

Application NDA019869 (NDA)

FDADec 26

Dextrose 10% In Plastic Container — DEXTROSE 70% IN PLASTIC CONTAINER

Application NDA019893 (NDA)

FDADec 26

Dextrose 10% In Plastic Container — DEXTROSE 50% IN PLASTIC CONTAINER

Application NDA019894 (NDA)

FDADec 26

Dextrose 10% In Plastic Container — DEXTROSE 70% IN PLASTIC CONTAINER

Application NDA019893 (NDA)

FDADec 26

Dextrose 10% In Plastic Container — DEXTROSE 50% IN PLASTIC CONTAINER

Application NDA019894 (NDA)

19912 events

FDAJul 2

Dextrose 10% In Plastic Container — DEXTROSE 50% IN PLASTIC CONTAINER

Application NDA020047 (NDA)

FDAJul 2

Dextrose 10% In Plastic Container — DEXTROSE 50% IN PLASTIC CONTAINER

Application NDA020047 (NDA)

19922 events

FDADec 7

Dextrose 10% In Plastic Container — DEXTROSE 5% IN PLASTIC CONTAINER

Application NDA020179 (NDA)

FDADec 7

Dextrose 10% In Plastic Container — DEXTROSE 5% IN PLASTIC CONTAINER

Application NDA020179 (NDA)

19952 events

FDASep 28

Dextrose 10% In Plastic Container — DEXTROSE 5% IN PLASTIC CONTAINER

Application NDA019971 (NDA)

FDASep 28

Dextrose 10% In Plastic Container — DEXTROSE 5% IN PLASTIC CONTAINER

Application NDA019971 (NDA)

19982 events

FDANov 23

Dextrose 10% In Plastic Container — DEXTROSE 25%

Application NDA019445 (NDA)

FDANov 23

Dextrose 10% In Plastic Container — DEXTROSE 25%

Application NDA019445 (NDA)

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)